Clinical Trials Logo

Filter by:
NCT ID: NCT03588546 Recruiting - Asthma Clinical Trials

FASENRA SCEI for Long-term Use

Start date: May 31, 2018
Phase:
Study type: Observational [Patient Registry]

The purpose of the investigation is to confirm the safety and efficacy under the post-marketing actual long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.

NCT ID: NCT03586973 Recruiting - Clinical trials for Advanced Hepatocellular Carcinoma

A Phase 2 Study of Cabozantinib in Japanese Patients With Advanced Hepatocellular Carcinoma

Start date: July 9, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Cabozantinib in Japanese patients with advanced hepatocellular carcinoma (HCC) who have received prior systemic anticancer therapy.

NCT ID: NCT03581071 Completed - Clinical trials for Chronic Kidney Disease

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease

Start date: October 6, 2016
Phase: Phase 1
Study type: Interventional

To evaluate the safety, pharmacokinetics, and pharmacodynamics in nondialysis (ND) and hemodialysis (HD) subjects with Chronic Kidney Disease (CKD) who receive a single administration of TS-143.

NCT ID: NCT03577795 Not yet recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society

ACO-Registry
Start date: June 30, 2018
Phase:
Study type: Observational [Patient Registry]

This study is a multicentered and non-interventional prospective cohort study. Study centers shall be the institutions where the examinations, adopted in the ACO diagnostic criteria9) from The Japanese Respiratory Society, are performed at least once a year as a part of their regular practice. Physicians participating in the study will consecutively register by means of central registration outpatients who have the characteristics of COPD in the ACO diagnostic criteria9) from The Japanese Respiratory Society, and who have been confirmed to satisfy the inclusion criteria whereas not violating the exclusion criteria.

NCT ID: NCT03573336 Not yet recruiting - Endometriosis Clinical Trials

Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis

VILLENDO
Start date: June 29, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the efficacy and safety of two doses of vilaprisan compared to placebo in women with symptomatic endometriosis. The secondary objective of this study is to evaluate the safety and tolerability of two different doses of vilaprisan in women with symptomatic endometriosis.

NCT ID: NCT03572985 Recruiting - Clinical trials for Healthy Participants

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3

Start date: June 27, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to collect alcohol calibration data for the driving simulator.

NCT ID: NCT03571607 Not yet recruiting - Clinical trials for Pneumococcal Infections

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Start date: July 12, 2018
Phase: Phase 3
Study type: Interventional

This study is to evaluate the safety, tolerability and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese subjects aged 6 to 64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.

NCT ID: NCT03570957 Not yet recruiting - Clinical trials for Seasonal Allergic Rhinitis

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Start date: July 2018
Phase: Phase 1
Study type: Interventional

The objective of this study is to investigate the safety, tolerability, and pharmacokinetics of MT-2990 in patients with Japanese cedar pollen-induced seasonal allergic rhinitis (JC-SAR). Additional objective of the study is to investigate the efficacy and pharmacodynamics profile of MT-2990 in an environmental exposure chamber (EEC) on Day 8, 29, 57, and 85.

NCT ID: NCT03570047 Active, not recruiting - Clinical trials for Non-valvular Atrial Fibrillation

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

CER3
Start date: May 8, 2018
Phase:
Study type: Observational

An anticoagulation therapy is a critical treatment to prevent thromboembolism in non-valvular AF (NVAF) patients. Warfarin, a vitamin K antagonist, is the first oral anticoagulant approved for the treatment for prevention of thromboembolism and it had long been the only oral anticoagulant until the first non-vitamin K antagonist oral anticoagulants (NOACs). However, its safety and effectiveness remains unknown in real-world clinical practice in Japan

NCT ID: NCT03569436 Recruiting - Clinical trials for Cancer of Head and Neck

Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread

Start date: February 14, 2018
Phase:
Study type: Observational

Non-interventional study in Japan of participants with HNC recurring or that has spread and who are treated with nivolumab